A National Cancer Institute of Canada Clinical Trials Group Study – IND.135: Phase I/II study of irinotecan (camptosar), oxaliplatin and raltitrexed (tomudex) (COT) in patients with advanced colorectal cancer
Titel:
A National Cancer Institute of Canada Clinical Trials Group Study – IND.135: Phase I/II study of irinotecan (camptosar), oxaliplatin and raltitrexed (tomudex) (COT) in patients with advanced colorectal cancer
Auteur:
Maroun, J.A. Jonker, D. Seymour, L. Goel, R. Vincent, M. Kocha, W. Cripps, C. Fisher, B. Lister, D. Malpage, A. Chiritescu, G.